EUVIMEDEUVIMED entdecken
Crossref

Immediate reactions to proton pump inhibitors: Clinical findings and testing outcomes

Nurullah Yekta Akçam, Güzin Özden, Leyla Çevirme, Merve Erkoç

Allergologia et Immunopathologia · 2025

DOI: 10.15586/aei.v53i6.1463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergologia et Immunopathologia, 2025. Verfasst von Nurullah Yekta Akçam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology and Allergy, Mersin City Training and Research Hospital, Mersin, Turkey. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Drug Hypersensitivity, Hypersensitivity, Immediate. Gefördert von: None..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Proton pump inhibitors (PPIs) are identified to cause immediate hypersensitivity reactions and cross-reactivity among them. In this study, we aimed to describe the clinical features of immediate-type hypersensitivity reactions caused by PPIs, the results of drug tests performed with PPIs, and the cross-reactivity between PPIs. There are immediate hypersensitivity reactions with PPIs and there may be cross-reactivity between PPIs. In this study, we aimed to describe the clinical features of immediate-type hypersensitivity reactions caused by PPIs, the results of drug tests performed with PPIs and the cross-reactivity between PPIs.

Methods

Adult patients who described an immediate hypersensitivity reaction to PPIs between March 1, 2017 and March 1, 2023 were evaluated.

Results

Of the 47 patients included in the study, 89.4% were females, and the suspected PPI in 68% of the patients was lansoprazole. Anaphylaxis accounted for 72.3% of reactions, and the most common reaction was grade 2 (42.6%) according to Ring Messmer. Those who had two or more reactions to the same or different PPI were 51.1% of patients. A positivity rate of 43.8% was observed in the skin prick test with the suspected drug, 33.3% in the intradermal test, and 100% in the provocation test. There is varying potential for cross-reactivity among five different PPIs.

Conclusions

İmmediate hypersensitivity reactions are observed among PPIs, particularly to lansoprazole, with the majority of reactions being anaphylaxis. Multiple life-threatening reactions can be prevented by increasing awareness of allergies to PPIs. Cross-reactivities among PPIs are variable, and further studies are needed to elucidate cross-reactivity with PPIs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsDrug HypersensitivityHypersensitivity, ImmediateHumansFemaleMaleCross ReactionsMiddle AgedAdultSkin TestsAgedLansoprazoleAnaphylaxisRetrospective Studies

Stichwörter der Autor:innen

anaphylaxiscross-reactivityimmediate hypersensitivitylansoprazoleproton pump inhibitor

Substanzen

Proton Pump InhibitorsLansoprazole

Autor:innen und Institutionen

  • Division of Immunology and Allergy, Mersin City Training and Research Hospital, Mersin, Turkey.
  • Division of Immunology and Allergy, Adana City Training and Research Hospital, Yüreğir, Adana, Turkey; guzin.ozden1@sbu.edu.tr.
  • Division of Immunology and Allergy, Adana City Training and Research Hospital, Yüreğir, Adana, Turkey.

Förderung

  • None.

Zitieren

APA

Akçam, N. Y., Özden, G., Çevirme, L., & Erkoç, M. (2025). Immediate reactions to proton pump inhibitors: Clinical findings and testing outcomes. Allergologia et Immunopathologia. https://doi.org/10.15586/aei.v53i6.1463

Vancouver

Akçam NY, Özden G, Çevirme L, Erkoç M. Immediate reactions to proton pump inhibitors: Clinical findings and testing outcomes. Allergologia et Immunopathologia. 2025. doi:10.15586/aei.v53i6.1463

BibTeX
@article{Akam2025,
  author = {Akçam, Nurullah Yekta and Özden, Güzin and Çevirme, Leyla and Erkoç, Merve},
  title = {Immediate reactions to proton pump inhibitors: Clinical findings and testing outcomes},
  journal = {Allergologia et Immunopathologia},
  year = {2025},
  doi = {10.15586/aei.v53i6.1463}
}
Kostenlos starten →